Page last updated: 2024-09-03

wr 99210 and levoleucovorin

wr 99210 has been researched along with levoleucovorin in 1 studies

Compound Research Comparison

Studies (wr 99210)	Trials (wr 99210)	Recent Studies (post-2010) (wr 99210)	Studies (levoleucovorin)	Trials (levoleucovorin)	Recent Studies (post-2010) (levoleucovorin)
59	0	12	10,988	3,248	3,796

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jacobus, DP; Kinyanjui, SM; Mberu, EK; Watkins, WM; Winstanley, PA	1

Other Studies

1 other study(ies) available for wr 99210 and levoleucovorin

Article	Year
The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. The American journal of tropical medicine and hygiene, 1999, Volume: 60, Issue:6 Topics: Animals; Antidotes; Antimalarials; Asia, Southeastern; Dose-Response Relationship, Drug; Drug Resistance; Folic Acid; Folic Acid Antagonists; Hematinics; Humans; Inhibitory Concentration 50; Kenya; Leucovorin; Malaria, Falciparum; Plasmodium falciparum; Prodrugs; Proguanil; Triazines	1999

Article

Year

The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.

The American journal of tropical medicine and hygiene, 1999, Volume: 60, Issue:6

Topics: Animals; Antidotes; Antimalarials; Asia, Southeastern; Dose-Response Relationship, Drug; Drug Resistance; Folic Acid; Folic Acid Antagonists; Hematinics; Humans; Inhibitory Concentration 50; Kenya; Leucovorin; Malaria, Falciparum; Plasmodium falciparum; Prodrugs; Proguanil; Triazines

1999